AngioDynamics (NASDAQ:ANGO) Updates FY25 Earnings Guidance

AngioDynamics (NASDAQ:ANGO - Get Free Report) updated its FY25 earnings guidance on Wednesday. The company provided earnings per share guidance of ($0.38)-($0.34) for the period, compared to the consensus earnings per share estimate of ($0.40). The company issued revenue guidance of $282-288 million, compared to the consensus revenue estimate of $283.86 million. AngioDynamics also updated its FY 2025 guidance to -0.380--0.340 EPS.

Analysts Set New Price Targets

Several analysts recently weighed in on the company. Canaccord Genuity Group decreased their target price on AngioDynamics from $13.00 to $12.00 and set a "buy" rating for the company in a research note on Friday, October 4th. HC Wainwright reissued a "buy" rating and issued a $14.00 price objective on shares of AngioDynamics in a research report on Tuesday, December 10th.

AngioDynamics Price Performance

Shares of NASDAQ ANGO traded up $3.54 during mid-day trading on Wednesday, hitting $12.94. The company had a trading volume of 4,421,281 shares, compared to its average volume of 1,328,826. AngioDynamics has a 12 month low of $5.26 and a 12 month high of $13.13. The firm has a market cap of $525.80 million, a P/E ratio of -2.12 and a beta of 0.59. The business's 50-day simple moving average is $7.87 and its 200-day simple moving average is $7.30.

AngioDynamics (NASDAQ:ANGO - Get Free Report) last announced its quarterly earnings data on Wednesday, January 8th. The medical instruments supplier reported ($0.04) EPS for the quarter, topping analysts' consensus estimates of ($0.11) by $0.07. The company had revenue of $72.90 million during the quarter, compared to the consensus estimate of $70.93 million. AngioDynamics had a negative return on equity of 5.86% and a negative net margin of 83.95%. The company's quarterly revenue was down .1% on a year-over-year basis. During the same quarter last year, the company earned ($0.05) EPS. As a group, sell-side analysts predict that AngioDynamics will post -0.41 EPS for the current year.

AngioDynamics Company Profile

AngioDynamics, Inc, a medical technology company, engages in the design, manufacture, and sale of medical, surgical, and diagnostic devices for the use in treating peripheral vascular disease, and oncology and surgical settings in the United States and internationally. The company offers Auryon Atherectomy system that is designed to deliver an optimized wavelength, pulse width, and amplitude to remove lesions while preserving vessel wall endothelium.